Delivery Order 36C25722D0051-36C25726N0188
- Not listed
- The Department of Veterans Affairs (VA) has awarded a $18,466.34 firm-fixed-price delivery order contract to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., to provide AlloMap molecular testing services for heart transplant patient monitoring. This delivery order is placed against a single-award indefinite delivery contract (IDC) valued at $787,000 that Caredx Lab Solutions holds with the VA's Veterans Integrated Service Network 17 (VISN 17), which runs through June 2027. The contract...
- CareDx Lab Solutions Inc., headquartered in West Chester, Pennsylvania, was awarded a delivery order valued at $23,972.68 by the Department of Veterans Affairs Veterans Integrated Service Network 17 (VISN 17) on June 3, 2024. This firm fixed-price contract, which carries no set-aside designation, represents a delivery order issued against an existing single-award indefinite delivery contract valued at $787,000 with an ultimate completion date of June 2, 2027. The delivery order calls for the...
- Caredx Lab Solutions Inc. was awarded a firm fixed price delivery order against the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 indefinite delivery contract to provide AlloMap molecular testing services. The $6,480 order has a completion date of June 2, 2023 and was awarded on June 3, 2022 to support the VISN's care of veteran transplant recipients in the Dallas, Texas area. The single award IDC, which has a potential value of $675,000 and...
- Caredx, Inc., a medical technology company specializing in advanced diagnostic solutions for transplant patients, was awarded a delivery order by Veterans Integrated Service Network (VISN) 16 on April 1, 2026, to provide laboratory testing services for post-transplant care. The firm fixed-price delivery order carries a ceiling value of $770,804.50 and extends through March 31, 2027. This award was not designated as a set-aside contract and will be performed in Houston, Texas. The contract...
- Caredx, Inc., a medical technology company specializing in advanced diagnostic solutions for organ transplant patients, received a purchase order valued at $66,908.60 from the Veterans Integrated Service Network 17 (VISN 17) on December 15, 2023. The contract, which carries a firm fixed price structure with no set-aside designation, covers AlloSure kidney tests, AlloSure heart tests, and AlloMap heart tests. Performance is scheduled for completion by June 14, 2024, with services to be...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 17 to Caredx Lab Solutions Inc., a for-profit manufacturer of genomics-based solutions for transplant patients. The $59,931.70 contract provides CAREDX ALLOMAP molecular testing services to support post-transplant surveillance and patient management for heart transplant recipients within the VA network. The contract is an indefinite delivery vehicle with a...
- This federal contract award is for "TRANSPLANT LABORATORY TESTING" services provided by Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services to support organ transplant programs. The contract, valued at $205,530.69, was awarded by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9 (VISN 9). The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract valued at...
- This is a $193,171.00 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract is for laboratory reference testing services, specifically Caredx's specialized diagnostic solutions for organ transplant patients, including its AlloMap and AlloSure genetic and molecular testing products. The contract has an ultimate completion date of January 14,...
- This is a federal contract award to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $4,807,230.45, is for laboratory tests for post-transplant organ rejection and was awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of March 31, 2026....
- This federal contract award to Caredx, Inc., a for-profit medical testing company, is for the provision of specialized genetic testing services to support organ transplant programs for the U.S. Department of Veterans Affairs (VA). The contract, valued at $529,760.00, is a delivery order awarded under a larger Indefinite Delivery Vehicle (IDV) contract with a $1,963,141.20 ceiling for genetic blood testing services. Caredx will supply the VA with its AlloSure kidney and heart tests, AlloMap heart...
- 36C25722D0051Indefinite Delivery Contract
- 36C25722D0051-36C25726N0188Delivery Order
Caredx Lab Solutions Inc. was awarded a delivery order valued at approximately $60K by the Department of Veterans Affairs Veterans Integrated Service Network 17 for AlloMap molecular testing services. This award, issued on June 3, 2026, represents a continuation of an indefinite delivery contract initially established on June 3, 2022, with a total potential value of $787K and an ultimate completion date of June 2, 2027. The contract utilizes a firm fixed-price model with no set-aside designation, reflecting successful competition based on technical capability. Performance will take place in West Chester, Pennsylvania, where Caredx Lab Solutions manufactures its FDA-approved AlloMap genomics-based diagnostic test. The AlloMap test provides molecular surveillance and rejection risk assessment for post-transplant heart recipients within the VA network, particularly supporting clinical operations in the Dallas, Texas area. Caredx Lab Solutions has established itself as the sole approved provider of this specialized diagnostic service within VISN 17, enabling uninterrupted access to advanced genomic testing for veterans undergoing transplant care. The company has demonstrated consistent utilization of its diagnostic capabilities under this vehicle, with multiple delivery orders issued since inception, ranging from approximately $6,500 to $60K per order, underscoring the VA's ongoing reliance on this specialized molecular testing capability to support post-transplant patient management and outcomes.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Q301--OPT - CareDx - 36C25722D0051 + MOD (Line Item Changes) | 36C25724Q0409 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 | Special Notice 1/1 | 2/28/24, 10:42 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.9k | 1/14/26 |